Prophylactic intra-aortic balloon pump reduces C-reactive protein levels and early mortality in high-risk patients undergoing percutaneous coronary intervention

Acta Cardiologica

Volumn 66, Issue 4, 2011, Pages 499-504

  Gu, Jun ^a   Hu, Wei ^a   Xiao, Hongbing ^a   Feng, Xiaodi ^a   Song, Zhiping ^a   Chen, Yueguang ^a   Zhang, Dadong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Inflammatory response; Intra aortic balloon pump; Major adverse cardiovascular events; Myocardial infarction; Percutaneous coronary intervention

Indexed keywords

C REACTIVE PROTEIN; TROPONIN I;

AGED; AORTA BALLOON; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; FEMALE; HOSPITAL MORTALITY; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SHOCK, CARDIOGENIC; TROPONIN I;

EID: 80051980814     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.66.4.2126599     Document Type: Article

References (24)

1. French JK, Feldman HA, Assmann SF, Sanborn T, Palmeri ST, Miller D, Boland J, Buller CE, Steingart R, Sleeper LA, Hochman JS; SHOCK Investigators. Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial. Am Heart J 2003; 146: 804-810.
2. Ohman EM, Nanas J, Stomel RJ, Leesar MA, Nielsen DW, O'Dea D, Rogers FJ, Harber D, Hudson MP, Fraulo E, Shaw LK, Lee KL; TACTICS Trial. Thrombolysis and counter pulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. J Thromb Thrombolysis 2005; 19: 33-39.
3. Schmuziger M, Christenson JT, Maurice J, Mosimann E, Simonet F, Velebit V. Myocardial revascularization for the second time. Analysis of 458 reoperations and 2645 single operations. Cardiovasc Surg 1994; 2: 623-629.
4. Hochman JS, Buller CE, Sleeper LA, Boland J, Dzavik V, Sanborn TA, Godfrey E, White HD, Lim J, LeJemtel T. Cardiogenic shock complicating acute myocardial infarction-etiologies, management and outcome: a report from the SHOCK trial registry. J Am Coll Cardiol 2000; 36: 1063-1070.
5. Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM, Chou TM; Investigators in the National Registry of Myocardial Infarction 2. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J 2001; 141: 933-939.
6. Mishra S, Chu WW, Torguson R, Wolfram R, Deible R, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R. Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol 2006; 98: 608-612.
7. Stone GW, Marsalese D, Brodie BR, Griffin JJ, Donohue B, Costantini C, Balestrini C, Wharton T, Esente P, Spain M, Moses J, Nobuyoshi M, Ayres M, Jones D, Mason D, Grines L, O'Neill WW, Grines CL. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. J Am Coll Cardiol 1997; 29: 1459-1467.
8. Vijayalakshmi K, Kunadian B, Whittaker VJ, Wright RA, Hall JA, Sutton A, Muir D, de Belder MA. Intra-aortic counterpulsation does not improve coronary flow early after pci in a high-risk group of patients: observation from a randomized trial to explore its mode of action. J Invasive Cardiol 2007; 19: 339-346.
9. Briguori C, Sarais C, Pagnotta P, Airoldi F, Liistro F, Sgura F, Spanos V, Carlino M, Montorfano M, Di Mario C, Colombo A. Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J 2003; 145: 700-707.
10. Briguori C, Airoldi F, Chieffo A, Montorfano M, Carlino M, Sangiorgi GM, Morici N, Michev I, Iakovou I, Biondi-Zoccai G, Colombo A. Elective versus provisional intraaortic balloon pumping in unprotected left main stenting. Am Heart J 2006; 152: 565-572.
11. Sjauw KD, Engström AE, Vis MM, van der Schaaf RJ, Baan J Jr, Koch KT, de Winter RJ, Piek JJ, Tijssen JG, Henriques JP. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 2009; 30: 459-468.
12. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
13. Bae EH, Lim SY, Jeong MH, Park HW, Lim JH, Hong YJ, Kim W, Kim JH, Cho JG, Ahn YK, Park JC, Suh SP, Ahn BH, Kim SH, Kang JC. Long-term predictive factors of major adverse cardiac events in patients with acute myocardial infarction complicated by cardiogenic shock. Korean J Intern Med 2005; 20: 8-14.
14. Karakas M, Koeig W. CRP in cardiovascular disease. Herz 2009; 34: 607-613.
15. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with high C-reactive protein. N Engl J Med 2008; 359: 2195-2207.
16. Dimitrijević O, Stojcevski BD, Ignjatović S, Singh NM. Serial measurements of C-reactive protein after acute myocardial infarction in predicting one-year outcome. Int Heart J 2006; 47: 833-842.
17. Dibra A, Mehilli J, Braun S, Hadamitzky M, Baum H, Dirschinger J, Schühlen H, Schömig A, Kastrati A. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting. Am Heart J 2005; 150: 344-350.
18. Hong YJ, Mintz GS, Kim SW, Okabe T, Bui AB, Pichard AD, Satler LF, Waksman R, Weissman NJ. Impact of plaque rupture and elevated C-reactive protein on clinical outcome in patients with acute myocardial infarction: an intravascular ultrasound study. J Invasive Cardiol 2008; 20: 428-435.
19. Onorati F, Santarpino G, Tangredi G, Palmieri G, Rubino AS, Foti D, Gulletta E, Renzulli A. Intra-aortic balloon pump induced pulsatile perfusion reduces endothelial activation and inflammatory response following cardiopulmonary bypass. Eur J Cardiothorac 2009; 35: 1012-1019.
20. Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter JM, Russ M, Schlitt A, Buerke U, Christoph A, Schmidt H, Winkler M, Thiery J, Werdan K, Buerke M. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: The prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 2010; 38: 152-160.
21. Roubille F, Cayla G, Picot MC, Pradet V, Massin F, Gervasoni R, Pasquie JL, Macia JC, Piot C, Leclercq F. C-reactive protein (CRP) after revascularized STEMI: Is CRP a prognostic factor? Rev Med Interne 2008; 29: 868-874 [in French].
22. Hoffmann R, Suliman H, Haager P, Christott P, Lepper W, Radke PW, Ortlepp J, Blindt R, Hanrath P, Weber C. Association of C-reactive protein and myocardial perfusion in patients with ST-elevation acute myocardial infarction. Atherosclerosis 2006; 86: 177-183.
23. Majstorov V, Pop Gjorceva D, Vaskova O, Vavlukis M, Peovska I, Maksimovic J, Kuzmanovska S, Zdraveska-Kocovska M. C-reactive protein in patients with normal perfusion and mild to moderate perfusion defects who have undergone myocardial perfusion imaging with 99m-Tc sestamibi gated spect. Prilozi 2008; 29: 67-76.
24. Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D, de Belder A, Redwood S; BCIS-1 Investigators. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA 2010; 304: 867-874.